Metabolomics is an emerging field which enables profiling of samples from living organisms in order to obtain insight into biological processes. A vital aspect of metabolomics is sample preparation whereby inconsistent techniques generate unreliable results. This technique encompasses protein precipitation, liquid-liquid extraction, and solid-phase extraction as a means of fractionating metabolites into four distinct classes. Improved enrichment of low abundance molecules with a resulting increase in sensitivity is obtained, and ultimately results in more confident identification of molecules. This technique has been applied to plasma, bronchoalveolar lavage fluid, and cerebrospinal fluid samples with volumes as low as 50 µl. Samples can be used for multiple downstream applications; for example, the pellet resulting from protein precipitation can be stored for later analysis. The supernatant from that step undergoes liquid-liquid extraction using water and strong organic solvent to separate the hydrophilic and hydrophobic compounds. Once fractionated, the hydrophilic layer can be processed for later analysis or discarded if not needed. The hydrophobic fraction is further treated with a series of solvents during three solid-phase extraction steps to separate it into fatty acids, neutral lipids, and phospholipids. This allows the technician the flexibility to choose which class of compounds is preferred for analysis. It also aids in more reliable metabolite identification since some knowledge of chemical class exists.
Introduction
Biological reactions generate metabolites as end products of cellular processes. Metabolomics is a collection of all the compounds present in an organism as a result of these processes. It provides a picture of the physiology of cells and reflects an organism's response to external or internal stimuli 1, 2 . Such stimuli could be environmental, toxicological, pharmacological, dietary, hormonal, or related to disease. Many metabolomic applications have and are currently being studied by researchers and include biomarker discovery 3 , nutrition studies 4 , food science 5 , and drug testing 6 . Regardless of the application, variations in data, contamination, and presence of false positives need to be reduced or preferably removed. In biomarker discovery or in the case of determining differences between a control and a disease group, or investigating effects of drugs on subjects, a biological fluid is chosen based on the questions being asked and the types of metabolites being investigated 7 . For example, if studying the immediate effects of an inhaled drug on the lungs of asthmatics, then exploring metabolites in bronchoalveolar lavage fluid (BALF) samples before and following administration would be preferential. To ensure that observed differences are due to actual biological variation rather than improper sample preparation technique, standardized and consistent laboratory protocol is essential 8 . Sample information must be carefully documented to ensure that variables such as biological fluid, animal strain, sampling time, subject age, gender, to name a few, are all considered and factored into the study 9 . In addition, to reduce the possibility of contamination or false positives, it is recommended that solvent blanks and instrument blanks be analyzed 10 .
For this protocol, the term "metabolites" will be used to refer to the actual compounds identified. Using vendor software, an initial peak finding algorithm is used to detect mass spectral peaks. These peaks are aligned based on mass-to-charge (m/z) ratio and retention time. A second algorithm is then used to combine multiple features into a single compound. This includes such features as sodium, potassium, or ammonium adducts in the positive ionization mode, and chloride in the negative ion mode. Additional options in the software include features such as dimers and other adducts. Using glucose as an example, with peaks at 181.0707 m/z (M+H), 198.0972 m/z (M+NH 4 ), and 203.05261 m/z (M+Na), there would be three peaks corresponding to the same compound using the first algorithm. However when the second algorithm, which is based on molecular formula, is applied these three adducts become grouped together resulting in one compound.
Metabolites can cause interferences within samples due to the complexity of compounds present. The presence of thousands of metabolites in one sample causes signal suppression particularly of the lower abundance metabolites. Sample cleanup to remove interfering proteins, and 4. Create hydrophobic stock solutions using a variety of isotopically labeled standards and/or other non-polar compounds which are exogenous to the sample being analyzed; stock concentrations of 17:0 fatty acid (4 mg/ml), 19:1 fatty acid (4 mg/ml), 17:0 ceramide (2 mg/ml), 17:0 PE (1.75 mg/ml), 15:0 PC (2 mg/ml), and testosterone-D 2 (1 mg/ml). From each stock, create one solution in 1:1 chloroform:methanol with all standards to a final concentration of 50 µg/ml 17:0 ceramide, 100 µg/ml 15:0 PC, 100 µg/ml testosterone-D 2 , 200 µg/ml 17:0 fatty acid, 200 µg/ml 19:1 fatty acid, and 200 µg/ml 17:0 PE in the standard mix. 5. Test the degree of ionization of each standard ahead of time using at least five different concentrations for each standard to determine the limit of detection and linearity of the instrument for these compounds. The concentration of the stock solution for each individual standard will vary depending on experimental design, and the concentration of each standard in the combined spiked standard may range from 20 μg/ml to 2 mg/ml depending on how well they ionize. 6. Create a spike mix of positive controls and add them to the samples at 1x, 2x, or 4x concentration levels to monitor quantitatively the strength of the sample preparation and the accuracy of the instrumental data. Final concentration of positive controls can be: 2 mg/ml D-glucose, 100 µg/ml alanine-D 3 , 200 µg/ml methylmalonic acid-D 3 , 20 µg/ml triglyceride-D 5 , and/or other hydrophobic and hydrophilic standards. Adjust the standard concentrations based on the sensitivity of the MS and HPLC instrumentation used for analysis. This is a critical step as errors here will drastically affect results (see Figure 5 in representative results). 1. Consistently aspirate the same amount of MTBE for ALL samples since the size of the pellet will vary among samples. Therefore, if only 900 µl can be decanted for the sample with the least amount of supernatant, then decant 900 µl for all samples.
Protein Precipitation
9. Repeat step 3.9, and combine the organic layer to the same glass culture tube prepared in step 3.7. 
Liquid-liquid Extraction
1. Using a glass pipette, add 3 ml MTBE to the dried methanol residual (from section 3, step 6), vortex 30 sec, add 750 µl of water, then vortex 10 sec per tube. 2. Spin ~200 x g for 10 min in a centrifuge at RT. 3. Aspirate 2.5 ml of the MTBE layer (without getting water) and transfer to a clean glass culture tube.
Note: This is a critical step as differences here will affect results. 2.5 ml of MTBE should be carefully decanted from the top layer because it allows a fixed volume to be decanted without pipetting the aqueous layer below. If the volume of sample at the start of the experiment was less than the indicated 100 μl for this method, scale the volume of MTBE to proportionally reflect this starting sample volume. 4. Add 3 ml MTBE to the remaining water part of sample, and vortex 10 sec per tube. 5. Spin ~200 x g for 10 min in the centrifuge at RT. 6. Aspirate 3 ml of MTBE (without getting water) and combine with MTBE tube. 7. Concentrate the remaining aqueous layer by drying under N 2 . 8. Re-suspend residue in 100 µl of water. 9. Add 400 µl of ice cold MeOH to the glass culture tube, vortex briefly, and then transfer to microcentrifuge tube. 10. Leave at -80 °C for 20-30 min. Spin at 0 °C for 15 min at 18,000 x g. Note: It is recommended to place the entire sample rack in a -80 °C freezer as this will allow any remaining protein to precipitate out in the methanol. If a -80 °C freezer is not available, other options are: storing at -20 °C, placing the samples on dry ice, or keeping them in an ice bucket. It is important to consistently store the samples in a cold environment and at the same temperature to allow precipitation. 11. Aspirate 450 µl of supernatant and transfer to a clean microcentrifuge tube. Dry completely in a vacuum centrifugal concentrator at no more than 45 °C. (Takes about 1-2 hr). 12. Resuspend dried supernatant in 200 µl of 5% acetonitrile/water. Vortex briefly. Freeze at -80 °C.
2. When completely dry, stop the flow of nitrogen and quickly resuspend in 1 ml chloroform (CHCl 3 ) using a glass pipette. Vortex briefly.
Note: Solvents such as CHCl 3 have low viscosity. During pipetting, low surface tension causes solvent loss from the pipette. It is recommended that the pipette tip be prewet at least twice to allow equilibration between the solvent being pipetted and the space in the pipette. A gas-tight syringe can also be used if available. 3. Set up an SPE vacuum manifold and NH 2 SPE columns for fractionation. 4. Warm samples to RT and always keep suspended under a steady flow of N 2 . Warming to RT will allow lipid resuspension and the nitrogen will prevent oxidation and polymerization of lipids. 5. Wash and condition SPE cartridge 2x with 400 µl hexane. Discard waste and replace with new glass collection tube. 6. Add sample to SPE column, collect flow through in glass tubes. 7. With glass pipette add 1 ml of 2:1 CHCl 3 :IPA, collect flow through in same glass tubes (this is the Neutral Fraction). 8. Dry the neutral fraction under N 2 to minimize oxidation (takes about 10-15 min). 9. With glass pipette add 1 ml of 5% acetic acid in diethyl ether, collect flow through in new glass tubes (this is the Fatty Acid Fraction). 10. Dry the fatty acid fraction under N 2 to minimize oxidation (takes about 10-15 min). 11. Use plastic tips to add 800 µl of methanol to SPE cartridge, and collect flow-through in 15 ml plastic conical tubes (this is the Phospholipid Fraction). 12. Transfer phospholipid fraction to 1.5 ml centrifuge tubes. Dry the samples with a vacuum centrifugal concentrator at 45 °C (takes about 1-1.5 hr). 13. Resuspend each of the samples from the three fractions in 200 µl of 100% methanol, vortex, and transfer to autosampler vials screw-cap for storage.
Sample Storage Conditions
1. Store all samples at -80 °C until ready for instrument analysis. Note: Extracted samples, reconstituted in organic solvent may be stored at -20 °C. However this is not recommended as potential metabolites of interest will degrade at this temperature. Liquid nitrogen storage is also not recommended as investigators have reported contamination issues, special storage vials are needed, and there is lack of homogeneity in the chamber causing wide temperature fluctuations. 2. If sample volumes are small (<100 µl), use inserts in the vials to prevent solvent evaporation in the headspace during storage. 3. Avoid freeze-thaw of the samples. Thaw the samples only once, right before instrument analysis. Repeated freeze-thaws result in sample degradation. 6. Set the autosampler temperature to 4 °C, the column temperature to 20 °C, the injection volume to 2 µl and the flow rate to 0.5 ml/min. 7. Use 50% acetonitrile in 10 mM ammonium acetate, pH 5.8 for mobile phase A, and 90% acetonitrile in 10 mM ammonium acetate pH 5.8 for mobile phase B. 8. Run the following gradient elution profile: Start at 100% B from 0 to 2 min, then decrease to 50% B from 2 to 15 min, followed by 5 min 0% B washing and 10 min post run.
Liquid Chromatography Conditions

Representative Results
The entire sample preparation technique was performed as described above and the most important and/or relevant aspects are presented below. Hydrophilic and hydrophobic internal standards were spiked into pooled plasma samples to perform direct comparisons of the internal standards and endogenous metabolite abundances using various extraction methods. Liquid chromatography-mass spectrometry (LC-MS) data was analyzed using qualitative and quantitative software and resulted in excellent recovery and separation of both the endogenous compounds and internal standards. Figure 1 demonstrates the effectiveness of the MTBE-SPE method in extracting both lipid standards (A) and endogenous compounds (B).
Overall, better extraction and coverage of the metabolites were obtained compared to other methods such as methanol extraction, or 'MTBE only' extraction when the number of features was compared using qualitative and quantitative software following LC-MS analysis. For example, using only methanol extraction, the variation for creatinine-D 3 was 15.2%. However, with MTBE LLE, this was reduced to 1.04% CV. Using MTBE, the reproducibility of lipids and aqueous compounds were <8% and <5% respectively, compared to a simpler methanol extraction which resulted in larger variation of 29% and 15% respectively for lipids and aqueous compounds. The internal standards used to monitor lipid recoveries -testosterone-D 2 , C17 ceramide, 15:0 PC, and 17:0 PE increased by 26%, 200%, 100%, 400% respectively compared to using methanol alone. Similar increases were detected for fatty acid internal standards and phosphotidylcholine and phosphotidylethanolamine endogenous metabolites. Other endogenous metabolites such as sphingosines, ceramides, diacylglycerols, triacylglycerols, cholesterol, and sphingomyelin were either not detected using methanol or were detected at negligible levels. However these endogenous lipids were easily detected using MTBE extraction.
In our analysis comparing standard protocols, the following results were obtained: Methanol precipitation alone resulted in 1,851 metabolites, methanol-ethanol precipitation gave 2,073 metabolites, MTBE with liquid-liquid extraction gave 3,125, and MTBE with liquid-liquid and solid- Figure 2 demonstrates the efficiency in separating the hydrophobic metabolites into their respective chemical classes for more confident metabolite identification. There is minimal overlap of the compounds identified in the three lipid fractions following SPE. In support, Figure 3 shows the recovery of the internal standards demonstrating that ISTD's were eluted in the fraction related to their chemical class.
Quality control samples are used to evaluate the quality of the sample preparation, to determine any batch effects when multiple days of analysis are required for a large sample set, and to monitor instrument reproducibility. Chromatograms are examined to ensure that spiked-in standards are greater than 90% recovered with mass error of less than ± 3 ppm and retention time window of less than ±5%. If these criteria are not met, the results are discarded and the samples are reanalyzed. In a case of batch effects whereby a shift in retention is observed for one batch, the data analysis software can correct for this. A previously prepared batch of pooled plasma samples underwent sample preparation. The fractions were then sub-aliquoted into autosampler vials and stored at -80 °C for use in monitoring instrument conditions throughout every sample analysis. Table 1 shows the results from these spike-in standards. The fatty acid negative ionization mode fraction (data not shown in table) was not used for analysis because the % CV of the spike-in standards for the QC sample was greater than 10%. The dataset for that fraction was therefore discarded and the instrument inspected and maintained. Table 2 shows the results from endogenous metabolites in the samples following three different days of sample preparation and triplicate instrument injections. The endogenous metabolites in the sample preparation QC samples are all reproducible, signifying the strength of the sample preparation as well as the instrument injection reproducibility.
When sample preparation steps are not properly followed, however, unreliable and inconsistent results are obtained. Figure 4 shows the results when the protein precipitation step of the method is not followed as outlined. Three operators, A, B, and C performed the same sample preparation procedure on pooled plasma samples. Operator A, rather than pipetting the required amount of supernatant per the experimental protocol, instead pipetted >1 ml for both washes with some of the pellet. This not only resulted in a higher number of false positives for that fraction, but increased the variability of the data.
The chromatographic reproducibility of the data can be seen in Figure 7 . Pooled plasma samples were prepared in triplicate on separate days using protein precipitation, liquid-liquid extraction, and solid-phase extraction as described in this protocol. Each fraction was analyzed using the chromatographic separation described in section 7 of the protocol. Samples were then injected in triplicate on the LC-MS to evaluate instrument and sample preparation reproducibility. This consistent overlap demonstrates both the strength of the reproducibility of the sample preparation when prepared on three different days, as well as the strength of the chromatographic method in producing reproducible results. An increase in chemical noise is observed for the negative ionization mode of the fatty acid fraction. This may occur due to contaminants in the LC-MS solvents and can result in inconsistent quantitative metabolomic results. Therefore only metabolites which eluted prior to 9 min were analyzed.
When running long worklists, a loss of instrument sensitivity and change in buffer concentrations can occur over time resulting in decreased signal intensity and retention time shift. If the retention time overlap variation is less than 5% and the signal intensity variation is less than 10%, the data is still within standard laboratory limits. Analysis software can be used to align and normalize the data to correct for instrument and retention time drift. However, if the variation is large, then the reason has to be determined. Once this is rectified, the samples can be reanalyzed. Table 1 . Quality control results from spiked internal standards. Pooled plasma samples from an emphysema mouse model dataset were analyzed to monitor instrument conditions on a daily basis for this multi-week study. Quantitative analysis software was used to determine the peak areas of the internal standards, (n = number of instrument QC injections). Table 2 . Quality control results from endogenous metabolites. Pooled plasma samples from a human disease dataset were analyzed to monitor sample preparation reproducibility on separate days. Samples were prepared in triplicate over three days, (n = 9 prep QC injections).
Fraction
Discussion
One goal of clinical metabolomic studies is to identify changes in the metabolome related to disease or treatments. Therefore sample preparation techniques need to be robust, consistent, and transferable from technician to technician and from laboratory to laboratory 22 . The resulting data needs to be representative of the sample, and identified changes need to reflect the sample set rather than sample preparation errors. Therefore accurate pipetting, correct temperature, efficient decanting of immiscible layers, drying under nitrogen, and use of the same brands and sizes of glassware and tips are necessary.
During the protein precipitation step, it is crucial that the same amount of solution is decanted from each pellet. This reduces variation in volume and as such reduces variation in sample data. This protein precipitation step is necessary for metabolomic studies and cannot be skipped since it removes protein from the samples prior to small molecule profiling analysis on the mass spectrometer. It eliminates pathogens and large macromolecules, and releases bound metabolites from proteins 7 . Lack of protein accumulation in the samples expands the HPLC column lifetime and increases the accuracy and quality of results. Figure 5 is a depiction of the protein pellet formed when performing this technique on plasma samples. This allows the detection of the small molecules, enhances ion abundance, and reduces matrix effects from proteins in the sample. In addition, since it is assumed that all proteins are removed in this step, the amino acids which are detected during LC-MS analysis would originate from metabolic changes rather than from protein breakdown.
The liquid-liquid extraction step is critical since it separates the hydrophilic and hydrophobic metabolites into two immiscible layers. Figure 6 shows the LLE procedure and a representation of the LLE layer. An improper separation of the two layers results in metabolites either being lost or being eluted in both fractions. Careful application of this step reduces the number of hydrophilic compounds which appear in the hydrophobic fraction. The results for these compounds become unreliable since it cannot be determined which fraction contains the representative results. When done correctly, metabolite overlap is reduced.
To prevent oxidative degradation, particularly in lipids but also in small molecules which may contain thiol groups for example, exposure to oxygen has to be kept to a minimum. Therefore, this procedure is always performed under nitrogen to reduce/prevent oxidation of lipid or thiol containing compounds. In addition, transfer of sample and/or solution is rapid (within the first minute) to reduce oxygen exposure, then samples are quickly placed under a steady stream of nitrogen to dry down. Once dried, they are immediately resuspended in 100% methanol for the above discussed reasons.
Storage considerations are important in maintaining the viability of samples for later analysis. If samples are stored incorrectly, degradation or decomposition can occur. Ideally, samples should be stored in screw cap amber vials away from light to prevent degradation of light sensitive species. Samples should also be kept frozen at -80°C to prevent metabolite degradation [23] [24] [25] . Although not discussed in detail here, samples are always kept at 4°C in the autosampler tray during LC-MS analysis. This ensures that all samples are kept at a constant temperature and that changes in ambient temperature do not affect the viscosity, solubility, or stability of the samples. It is recommended that the manual aspects of this procedure, such as LLE and SPE, be practiced in order to gain confidence and comfort with the steps involved.
A few limitations exist for this technique. Discreet separation of the hydrophobic and hydrophilic metabolites is not guaranteed as certain compounds will inherently partition into both fractions due to their chemical composition and charge state. In addition as shown in Figure 4 , improper technique during the protein pellet extraction step can result in poor metabolite reproducibility in both the samples and quality controls. This affects the statistics, especially in small datasets because the statistical power is not available. Therefore it is crucial that this step be performed exactly the same every time for each sample. Another limitation is time. Although there are stop points throughout this protocol where samples can be frozen and the prep continued the following day, an entire day should be set aside to perform this procedure. Thirdly, not every compound within a biological sample can be evaluated for ion suppression. Since it is not possible to identify how the matrix is affecting each individual metabolite, the current option is to evaluate the internal standards which theoretically mimic some classes of endogenous metabolites. Lastly, absolute identifications cannot be performed solely with this method. Tandem MS in collaboration with database searches and standards are required for absolute metabolite identification.
An important part of metabolomics is the identification of compounds. Although not discussed in detail here, quality control samples were analyzed using LC-MS. Multiple sample preparation blanks and instrument blanks were prepared for use as background subtraction to reduce the rate of false positives from contaminants, thereby resulting in more reliable metabolite hits. Following this step, the number of "molecular features" were grouped together based on m/z, retention time, isotope ratio, and adducts to produce a list of actual compounds. Although the list of compounds was greatly reduced, the results were more reliable as they were not based on multiple adducts from the same compound. The full method is comprehensive and allows isolation of hydrophobic metabolites such as neutral lipids, phospholipids, fatty acids, triglycerides, and steroids, while also isolating hydrophilic classes in the aqueous fraction, of which eicosanoids, sugars, flavonoids, and amino acids have been identified 12, 26 .
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